FDA Approves HIV Vaccine For Human Trials

The U.S. Food and Drug Administration has approved preliminary clinical human trials for an experimental HIV vaccine developed by researchers at the University of Western Ontario. Though there are 30 HIV vaccines being tested around this world, this new vaccine, SAV001, is the first to use a killed whole HIV-1 virus to activate the immune response in humans. If it is deemed safe in this first trial of 40 healthy people who are HIV-positive, it will enter a second trial where it will be tested on 600 HIV-negative volunteers from high-risk groups.